DURHAM, N.C., Feb. 27, 2020 /PRNewswire/ -- Parata Systems, a leading provider of pharmacy automation, including vial-filling, adherence packaging, and workflow and patient experience solutions, announces the launch of a new pouch packager, the PASS™ 36. Medication adherence programs can improve overall health outcomes and have been s

TEL AVIV, Israel, Feb. 27, 2020 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX), (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, announced today that a Notice of Allowance has been issued by the United States Patent and Trademark Office (USPTO) for a patent application claiming the use of motixafortide (BL-8040), a novel immunotherapy com

NEW YORK, Feb. 27, 2020 /PRNewswire/ -- Manhattan-based Amplicare, a leading SaaS provider of workflow automation platforms and clinical analytics for healthcare providers, has extended its strategic partnership with TempusDurham to expand its leadership team and accelerate growth.Under terms of the agreement, TempusDurham will inc

CARLSBAD, Calif., Feb. 27, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in antisense therapeutics, today announced that management will present a company overview at the following investor conferences:

CAMBRIDGE, England, Feb. 27, 2020 /PRNewswire/ -- SciBite today formally announced that Philippe Fauchet, OBE, has become the latest addition to its advisory board. Joining Alexander Karle and Diane Harbison, who initially formed the SciBite advisory board ba

PRINCETON, N.J., Feb. 27, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its ongoing collaboration with the University of Hawai'i at Manoa (UHM) and Hawaii Biotech

MONMOUTH JUNCTION, N.J., Feb. 27, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its blood puri

LITTLE FALLS, N.J., Feb. 27, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today that in line with its focus on key growth opportunities, Seth Yellin has been promoted to the newly created role of Executive Vice President and Chief Growth Officer. Mr. Yellin will continue to be based in

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2020 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology therapeutics, today announced that Bill Newell, Chief Ex

SAN CARLOS, Calif., Feb. 27, 2020 /PRNewswire/ -- Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, today announced that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer, will present at the following upcoming investo